| Follow us on Twitter |
In a related research in translation article about the implications of the research, Robert J. Weil, who was not involved in the trial, suggests that the study points the way “toward rational design of therapy for stratified groups of patients who share common molecular features” and a future that allows “cancer researchers and clinicians to reach toward the holy grail of individualized therapy”-Public Library of Science